These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31603483)
21. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Clark WH; Hood AF; Tucker MA; Jampel RM Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124 [TBL] [Abstract][Full Text] [Related]
22. Integrated diagnosis of nevi with severely atypical features and impact of second opinions. Uzundere C; Akay BN; Heper AO; Clark SP; Tschandl P; Kittler H J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1184-1189. PubMed ID: 36840392 [TBL] [Abstract][Full Text] [Related]
23. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL; J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823 [TBL] [Abstract][Full Text] [Related]
25. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228 [TBL] [Abstract][Full Text] [Related]
26. Who sends what: a comparison of dermatopathology referrals from dermatologists, pathologists and dermatopathologists. Goldenberg G; Camacho F; Gildea J; Golitz LE J Cutan Pathol; 2008 Jul; 35(7):658-61. PubMed ID: 18201232 [TBL] [Abstract][Full Text] [Related]
27. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'? Braun RP; Gutkowicz-Krusin D; Rabinovitz H; Cognetta A; Hofmann-Wellenhof R; Ahlgrimm-Siess V; Polsky D; Oliviero M; Kolm I; Googe P; King R; Prieto VG; French L; Marghoob A; Mihm M Dermatology; 2012; 224(1):51-8. PubMed ID: 22433231 [TBL] [Abstract][Full Text] [Related]
28. Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group. Massi D; Szumera-Ciećkiewicz A; Alos L; Simi S; Ugolini F; Palmieri G; Stanganelli I; Cook MG; Mandalà M Eur J Cancer; 2023 Aug; 189():112921. PubMed ID: 37280145 [TBL] [Abstract][Full Text] [Related]
29. Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center. Shoo BA; Sagebiel RW; Kashani-Sabet M J Am Acad Dermatol; 2010 May; 62(5):751-6. PubMed ID: 20303612 [TBL] [Abstract][Full Text] [Related]
30. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns. Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233 [TBL] [Abstract][Full Text] [Related]
31. Common and not so Common Melanocytic Lesions in Children and Adolescents. Yang C; Gru AA; Dehner LP Pediatr Dev Pathol; 2018; 21(2):252-270. PubMed ID: 29607755 [TBL] [Abstract][Full Text] [Related]
33. Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients. Takai S; Arai E; Shojiguchi N; Nakamura Y; Momose S; Fukuda T; Ishizawa K; Ogata D; Tsunemi Y; Nakamura K; Tsuchida T J Dermatol; 2023 May; 50(5):637-645. PubMed ID: 36539950 [TBL] [Abstract][Full Text] [Related]
34. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement. Barnhill RL; Elder DE; Piepkorn MW; Knezevich SR; Reisch LM; Eguchi MM; Bastian BC; Blokx W; Bosenberg M; Busam KJ; Carr R; Cochran A; Cook MG; Duncan LM; Elenitsas R; de la Fouchardière A; Gerami P; Johansson I; Ko J; Landman G; Lazar AJ; Lowe L; Massi D; Messina J; Mihic-Probst D; Parker DC; Schmidt B; Shea CR; Scolyer RA; Tetzlaff M; Xu X; Yeh I; Zembowicz A; Elmore JG JAMA Netw Open; 2023 Jan; 6(1):e2250613. PubMed ID: 36630138 [TBL] [Abstract][Full Text] [Related]
35. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Weinstock MA; Barnhill RL; Rhodes AR; Brodsky GL Arch Dermatol; 1997 Aug; 133(8):953-8. PubMed ID: 9267239 [TBL] [Abstract][Full Text] [Related]
36. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ. Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281 [TBL] [Abstract][Full Text] [Related]
37. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768 [TBL] [Abstract][Full Text] [Related]
38. Assessment of Diagnostic Performance of Dermatologists Cooperating With a Convolutional Neural Network in a Prospective Clinical Study: Human With Machine. Winkler JK; Blum A; Kommoss K; Enk A; Toberer F; Rosenberger A; Haenssle HA JAMA Dermatol; 2023 Jun; 159(6):621-627. PubMed ID: 37133847 [TBL] [Abstract][Full Text] [Related]
39. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? Skender-Kalnenas TM; English DR; Heenan PJ J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345 [TBL] [Abstract][Full Text] [Related]